Document is current
Any future updates will be listed below
-
Authors
Garrison-Desany, Henri M.
Hinojosa, Cecilia A. https://orcid.org/0000-0002-2577-6142
Tubbs, Justin D. https://orcid.org/0000-0002-6671-6816
Meyers, Jacquelyn L. https://orcid.org/0000-0003-3863-8555
Linnstaedt, Sarah D. https://orcid.org/0000-0001-5295-7072
House, Stacey L.
Beaudoin, Francesca L.
An, Xinming
Stevens, Jennifer S. https://orcid.org/0000-0003-4674-0314
Neylan, Thomas C. https://orcid.org/0000-0002-1572-2626
Clifford, Gari D.
Germine, Laura T. https://orcid.org/0000-0001-8690-8412
Rauch, Scott L.
Haran, John P. https://orcid.org/0000-0001-7311-1121
Storrow, Alan B. https://orcid.org/0000-0002-2893-808X
Musey, Paul I. Jr
Hendry, Phyllis L.
Sheikh, Sophia https://orcid.org/0000-0003-1939-3126
Jones, Christopher W.
Punches, Brittany E. https://orcid.org/0000-0002-7546-1966
Pascual, Jose L. https://orcid.org/0000-0002-1613-7912
Seamon, Mark J.
Harris, Erica
Pearson, Claire
Peak, David A.
Merchant, Roland C.
Domeier, Robert M.
O’Neil, Brian J.
Sergot, Paulina
Sanchez, Leon D. https://orcid.org/0000-0002-8807-0913
Bruce, Steven E. https://orcid.org/0000-0002-5807-4382
Harte, Steven E.
McLean, Samuel A. https://orcid.org/0000-0001-9482-3582
Ressler, Kerry J. https://orcid.org/0000-0002-5158-1103
Koenen, Karestan C. https://orcid.org/0000-0003-2978-7655
Denckla, Christy A.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (K99AA031333)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (U01MH110925, U01MH110925, U01MH110925)
Mayday Fund
One Mind
United States Department of Defense | United States Army | Army Medical Command | Medical Research and Materiel Command
- License Information
-
More Information
Article History
Received: 27 July 2024
Revised: 11 July 2025
Accepted: 1 September 2025
First Online: 24 October 2025
Competing interests
: Dr. Garrison-Desany has no competing interests related to this work, though received a contract from Indivior PLC from February to May 2025 for research unrelated to this manuscript. Dr. Hinojosa receives support from the National Institute of Alcohol Abuse and Alcoholism, K99AA031333. Dr. Neylan has received research support from NIH, VA, and Rainwater Charitable Foundation, and consulting income from Jazz Pharmaceuticals. In the last three years Dr Clifford has received research funding from the NSF, NIH and LifeBell AI, and unrestricted donations from AliveCor Inc, Amazon Research, the Center for Discovery, the Gates Foundation, Google, the Gordon and Betty Moore Foundation, MathWorks, Microsoft Research, Nextsense Inc, One Mind Foundation, and the Rett Research Foundation. Dr Clifford has financial interest in AliveCor Inc and Nextsense Inc. He also is the CTO of MindChild Medical with significant stock. These relationships are unconnected to the current work. Dr. Germine receives funding from the National Institute of Mental Health (R01 MH121617) and is on the board of the Many Brains Project. Her family also has equity in Intelerad Medical Systems, Inc. Dr. Rauch reported serving as secretary of the Society of Biological Psychiatry; serving as a board member of Community Psychiatry and Mindpath Health; serving as a board member of National Association of Behavioral Healthcare; serving as secretary and a board member for the Anxiety and Depression Association of America; serving as a board member of the National Network of Depression Centers; receiving royalties from Oxford University Press, American Psychiatric Publishing Inc, and Springer Publishing; and receiving personal fees from the Society of Biological Psychiatry, Community Psychiatry and Mindpath Health, and National Association of Behavioral Healthcare outside the submitted work. Dr. Jones has no competing interests related to this work, though he has been an investigator on studies funded by AstraZeneca, Vapotherm, Abbott, and Ophirex. Dr. Harte has no competing interest related to this work, though in the last three years he has received research funding from Aptinyx and Arbor Medical Innovations, and consulting payments from Memorial Sloan Kettering Cancer Center, Indiana University, The Ohio State University, and Dana Farber Cancer Institute. Dr. McLean has served as a consultant for Walter Reed Army Institute for Research, Arbor Medical Innovations, and BioXcel Therapeutics, Inc. Dr. Ressler has performed scientific consultation for Bioxcel, Bionomics, Acer, and Jazz Pharma; serves on Scientific Advisory Boards for Sage, Boehringer Ingelheim, Senseye, and the Brain Research Foundation, and he has received sponsored research support from Alto Neuroscience. Dr. Koenen’s has been a paid scientific consultant for the US Department of Justice and Covington Burling, LLP over the last three years. She receives royalties from Guilford Press and Oxford University Press.
